• Pharma
  • February 5, 2025
  • 108 views
Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

New Delhi:  Home-grown FMCG major Dabur has lowered the time of its strategic vision cycle from four years to three years aiming to create a more agile organisation amid a…

  • Pharma
  • January 4, 2025
  • 310 views
Dabur India expects low single-digit revenue growth in Q3

Dabur India on Friday said it expects to garner “low single-digit growth” in terms of consolidated revenue during the December quarter and a “flattish” operating profit growth. The company also…

  • Health
  • July 30, 2018
  • 158 views
Anti-Profiteering Body Put Patanjali Under Scanner

Anti-profiteering body investigating the Baba Ramdev’s Patanjali Ayurveda on the behalf of a complaint registered alleging that the Patanjali made profits with selling consumer goods like cosmetics, toothpaste, shampoo etc…

  • Pharma
  • June 17, 2018
  • 124 views
DGGI sent notice to Pharma firms for not cutting GST on Free supply

Indian Tax department sent notices to big pharma companies for not cutting Goods and Services Tax(GST) on free goods or samples to the retailers. With regard to this notice, tax…